Skip to main content

Table 1 Comparison between alive and dead patients affected by COVID-19

From: Right ventricular-arterial uncoupling independently predicts survival in COVID-19 ARDS

  Alive (n = 69) Dead (n = 25) p
Age (year) 62 ± 13 68 ± 12 0.033
Sex M (%) 53 (77) 17 (68) 0.549
Disease duration (day) 7.7 ± 3.3 7.7 ± 3.1 0.942
Lung disease (%) 17 (25) 11 (44) 0.079
Coronary artery disease (%) 14 (20) 3 (12) 0.545
Cardiovascular comorbidities
 Hypertension (%) 44 (64) 19 (76) 0.362
 Diabetes (%) 11 (16) 5 (20) 0.99
 Smoke (%) 7 (10) 8 (32) 0.021
 Obesity (%) 18 (26) 13 (52) 0.025
Treatment
 Anticoagulants (%) 69 (100) 24 (96) 0.097
 Hydroxycloroquine (%) 51 (74) 19 (76) 0.840
 Antivirals (%) 43 (62) 23 (92) 0.005
 Monoclonal antibodies (%) 8 (12) 10 (40) 0.005
 Corticosteroids (%) 14 (20) 6 (24) 0.98
Type of ventilation
 Nasal oxygen (%) 35 (51) 0 (0)  < 0.001
 Noninvasive ventilation (%) 22 (32) 0 (0)  < 0.001
 Intubation (%) 12 (17) 25 (100)  < 0.032
Biochemistry
 Creatinine (mg/dl) 1.3 ± 1.3 2.8 ± 1.4  < 0.001
 Cardiac Troponin I (pg/l) 365 ± 644 1245 ± 2049  < 0.002
 D-dimer (ng/ml) 317 ± 557 919 ± 974  < 0.001
 C-reactive protein (mg/dl) 10.6 ± 19.9 22.8 ± 27.3  < 0.023
 Procalcitonin (ng/ml) 0.6 ± 1.5 1.8 ± 2.0  < 0.005
 APTT (sec) 36.8 ± 6.7 40.6 ± 4.3 0.037
 NT-proBNP (pg/ml) 686 ± 1224 3375 ± 3891  < 0.001
 Interleukine-6 (ng/ml) 33.6 ± 33.4 246.4 ± 87.4  < 0.001
 PaO2/FiO2 ratio (mmHg) 270 ± 104 117 ± 56  < 0.001
  1. Value are represented as mean ± standard deviation or absolute value and (%)
  2. APTT partial thromboplastin time, NT-proBNP N-terminal prohormone of brain natriuretic peptide, PaO2 arterial partial pressure of oxygen, FiO2 fraction of inspired O2